Type I collagen, a major structural protein of the extracellular matrix, is distributed mainly in the skin, bones, and tendons. Functional type I collagen molecules are triplehelical structures composed of two al(I) and one a2(I) chains. The two polypeptide chains are encoded at the unlinked COLlAl and COL1A2 loci, respectively. The polypeptides are synthesized as precursor prootl or proox2 chains, which assemble within the cell into a triple-helical procollagen molecule. After secretion into the extracellular space, the procollagen propeptide domains at the N and C termini are proteolytically removed to produce functional collagen molecules which undergo fibrillogenesis (7, 21) .
The collagen chains are highly conserved in evolution, and the protein sequence of the ot chains of type I collagen differs as little as 4% between species as distant as mice and humans (19) . This high evolutionary conservation suggests that the primary sequence of the polypeptide chains is important for their biological function. Indeed, a number of point mutations are known which result in a dominant perinatal lethal form of osteogenesis imperfecta (8, 28, 30) . In these molecularly well-defined mutations a single amino acid substitution in one of the ot chains disturbs proper helix propagation and stability, leading to a severe functional defect of type I collagen. The molecular analysis of collagen defects has been limited by the availability of mutations in human patients.
One experimental approach for studying the physiological effects of mutations on collagen function would be to introduce a gene that encodes one polypeptide component of collagen into animals that express the other component. The transferred gene could be engineered in vitro to carry defined mutations of interest (26) . For this approach, the endogenous gene corresponding to the transferred gene must be functionally deleted, with no effect on the expression of the other subunit component. Movl3 mice carry a Moloney leukemia proviral gene in intron 1 of the COLlAl gene (13) . This results in a block of transcription of the gene in most tissues with the exception of odontoblasts (11, 14, 24) . Transcription of the ac2(I) gene, however, is not affected by this insertional mutation. Therefore, the introduction of wild-type or variant COLlAl genes into Movl3 cells should allow functional testing of a given mutation on collagen synthesis. To test the feasibility of this approach, we have previously introduced the human prool(I) collagen gene into prootl(I)-deficient Movl3 mouse cells and demonstrated that the human prootl(I) chain could associate with the endogenous proa2(I) chain to form stable mouse-human interspecies collagen I molecules (23) . Because these experiments were performed in tissue culture, the study did not address whether the interspecies collagen I heterotrimer would be functional in vivo.
In the present study we (2) were microinjected into the male pronucleus. The eggs were incubated overnight, and two cell embryos were transferred to the oviduct of pseudopregnant foster females.
Genotyping of mice. DNA was isolated from placenta or brain following disruption of the tissues in 100 mM NaCl-10 mM Tris (pH 8.0-25 mM EDTA in a Polytron homogenizer.
High-molecular-weight DNAs were isolated following digestion with proteinase K as described previously (11, 12) .
DNA was digested with the restriction enzyme EcoRI and separated on an 0.8% agarose gel. After transfer to GeneScreen Plus nylon membrane (Du Pont, NEN Research Products), the upper portions of the blots were hybridized with a 32P-labeled mouse-specific 0.65-kilobase (kb) BstEIIHpal fragment located in intron 1 of the mouse procd(I) collagen gene, which hybridizes to a 14-kb EcoRI fragment in wild-type mice and to a 23-kb EcoRI fragment in Movl3 mice. This probe does not hybridize to the human transgene.
To determine the sex of the animals, we hybridized the lower portions of the blots to a mouse Y chromosome-specific probe, pY2 (15) . To estimate the copy number of the human transgene in animals, we rehybridized the blots to pJB8 (18) , which is the parental cosmid of the vector used for cloning the human COLlAl gene, and estimated the copy number by densitometry of the films.
Northern (RNA) blot analysis. Total RNA was prepared from the limbs of day 18 embryos by the method of Auffray and Rougeon (1). Glyoxal-denatured RNA samples were separated on a 1% (wt/vol) agarose gel and transferred to GeneScreen Plus nylon membrane. Filters were hybridized to the oligo-labeled human prool(I) collagen cDNA clone pHuc (27) or to the end-labeled human-specific 43-base synthetic oligonucleotide probe which corresponds to nucleotides 180 to 222 of the transcribed region (23) . Hybridization was also performed by using the rat ox1-tubulin probe (16) , which serves as an internal control. S1 analysis. S1 analysis was performed to compare the steady-state mRNA levels between the human transgene and mouse endogenous gene in different tissues. Total tissue RNAs were prepared from 4-day-old newborn HuclI mice. To measure the mouse (xl(I) collagen mRNA, which served as an internal control, we isolated a 1.3-kb XbaI fragment from pl (11) . To measure the expression levels from the human ol(I) collagen transgene, we isolated a 1.4-kb XbaIHindlIl fragment from pHCH2.3 in which a 2.3-kb HindIll fragment (2) containing the 5' end of the human COLlAI gene was subcloned into pUC19. These two probes were 3' end labeled with 32P by using Klenow polymerase. RNA (5 ,ug from each tissue) was ethanol precipitated with a mixture of human and mouse S1 probes which were empirically determined to be in excess. After denaturing at 80°C, half of the hybridization was carried out at 58°C, the optimal hybridization temperature for the mouse probe, and the other half was carried out at 64°C, the optimal hybridization temperature for the human probe, for 16 Corp.). After labeling, the medium and cell layer fractions were separated for analysis and procollagen was precipitated from both fractions with 25% saturated (NH4),S04. The precipitates were dissolved in 0.05 M Tris hydrochloride-0.15 M NaCl (pH 7.5). Portions were then analyzed by sodium dodecyl sulfate (SDS)-gel electrophoresis on 5% (wt/vol) polyacrylamide gels, as previously described (3, 4) , under nonreducing conditions. Analysis of transgenic-mouse dermal collagens. Circular biopsies (diameter, 4 mm) were taken from day 19 embryo skin, diced, defatted with chloroform-methanol (2:1) , and lyophilized to a constant dry weight. Dermal collagens were then serially extracted with 0.05 M Tris hydrochloride-0.15 M NaCl (pH 7.5) and subjected to pepsin digestion (100 pg/ml in 0.5 M acetic acid) (3, 26) . Collagens solubilized in each extract were quantitatively loaded onto 5% (wt/vol) polyacrylamide gels for electrophoretic analysis. Collagen bands were stained with Coomassie blue (3, 26) and quantitated by densitometry by comparison with gel tracks loaded with a known amount of a type I collagen standard. Collagens not solubilized by these extractions were recovered from the insoluble residue by digestion with cyanogen bromide. and the resultant peptides were analyzed by electrophoresis on 12.5% (wt/vol) polyacrylamide and densitometry (9) .
Analyses of bone collagen. Samples of midshaft femoral and calvareal bone were dissected from term embryos. Bone was dried, weighed, and hydrolyzed. without prior decalcification, in 6 M HCI for 24 h at 108°C. Hydroxyproline and hydroxylysine were quantified by reverse-phase high-pressure liquid chromatography by the method of precolumn derivatization with phenyl isothiocyanate. Hydroxypyridinium cross-linking amino acids were resolved by reversephase high-pressure liquid chromatography and quantified by fluorescence by using an established method (10).
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a The copy number of the human transgene was determined by optical densitometry of DNA Southern blots. Filters were hybridized to pJB8, which is the parental cosmid of the vector used for cloning the human COLlAl gene.
b Abbreviations: m, male; f, female.
Histologic analysis. Newborn embryos were fixed in 10% buffered Formalin, dehydrated in graded alcohols and xylenes, and embedded in Paraplast Plus. Serial 4-,um sections were prepared from each embryo (approximately 200 to 300 per embryos) and stained with Harris hematoxylin and eosin (25) .
RESULTS
Derivation of transgenic mice carrying the human gene on an autosome or on the X chromosome. The human proal(I) collagen cosmid clone CG103, which includes the 18-kb structural region and 1.6 kb of 5' and 20 kb of 3' flanking sequences, was microinjected into the pronuclei of SJL/ C57BL Fl mouse embryos. Two transgenic mouse strains, HucI and Hucll, were derived, as determined by slot blot analysis of tail DNA with the cosmid pJB8 as a probe. Each of these strains carried a single complete copy of the human prootl(I) collagen gene in the germ line. The transgene in HucI mice was autosomally inherited (see below), whereas in HuciI mice it was X-linked. This was shown by crossing HucIl males carrying a single copy of the human gene to normal females. When the offspring were genotyped all daughters but no sons carried the transgene. Similarly, when hemizygous males and homozygous females were crossed, all sons carried one copy and all daughters carried two copies of the transgene ( 2) . In contrast to the hemopericardium observed in Movl3 homozygous embryos (19) , the pericardium in these embryos was without any evidence of bleeding. Evidence of more remote bleeding was seen in the abdominal cavity, manifested as clotted blood. The results described above indicated that a mouse-human interspecies collagen I heterotrimer can function in the animal and can promote the development of mutant embryos to birth. The failure of the human gene to rescue homozygous Movl3 animals beyond birth could be due to insufficient or inappropriate expression of the transgene or to structural alterations of the interspecies heterotrimer, resulting in functional impairment of the collagen fibrils. Therefore, collagen RNA and proteins were analyzed in transgenic fetuses.
Steady-state mRNA of the human proal(I) collagen gene in wild-type and Movl3 mice. A human-specific 43-base synthetic oligonucleotide probe was used to distinguish between human and mouse proal(I) collagen RNA, as described previously (23) . Figure 3 shows a Northern analysis of RNA isolated from day 18 Movl3 fetuses carrying the HucIl transgene. The Movl3 genotype, the number of human transgenes carried by each fetus, and the sex were determined as described in the legend to Fig. 1 and Materials and Methods and are indicated at the top of the figure. The upper panel shows hybridization to a human proal(I) collagen cDNA clones, pHuc (13) , which detects mouse as well as human proal(I) collagen RNA. To standardize the amount of RNA loaded on the gel, we also hybridized filters with the rat a1-tubulin probe (15 To test whether the transgene was transcribed in an appropriate tissue-specific manner, we quantitated the steady-state mRNA of the human transgene and the mouse endogenous gene by an S1 nuclease protection assay. For this, a 1.4-kb XbaI-HindIII fragment extending from a position 113 bases 3' of the human transcription start site into intron 1 was isolated from the human collagen construct pHCH2.3, and a 1.3-kb XbaI-XbaI fragment extending from a position 108 bases 3' of the mouse transcriptional start site into intron 1 was isolated from the mouse collagen construct pl. The human transcript protects 109 bases of the human probe, whereas the endogenous mouse transcript protects 82 bases of the mouse probe (Fig. 4C) . At the hybridization temperatures used, no signal arises from mouse-human cross hybridization owing to the sequence differences between the two genes (Fig. 4A) . Human-and mouse-specific collagen transcripts in RNA extracted from different tissues of HucIl animals were analyzed by the S1 protection assay. A signal at 82 base pairs, which is characteristic of mouse collagenspecific RNA, was strong in tissues such as heart, lung, and muscle, weaker in liver and kidney, and almost not detectable in brain and spleen. This is the expected tissue distribution of collagen RNA. Importantly, a band at 109 base pairs characteristic of the human collagen RNA was present in the same tissues as and at similar relative intensities to the endogenous mouse signal.
The results described above indicate that the human proosl(I) collagen gene is expressed not only in the same tissues as the endogenous mouse gene (Fig. 4) , but also at comparable levels (Fig. 3) . It (Fig. 5A) . These gels VOL. 10, 1990 . (Fig. SA) , indicating that contained normal levels of posttranslational mi lysine (4) . Normal levels of lysine hydroxylati sylation suggest that the association of the hur mouse a2(I) chains into a triple helix occurs efficiently, since interruptions to helix formation characteristically lead to increased lysine modification (4, 6 Rat 4i tubulin to 18% of the collagen was extracted with neutral salt buffer, 70 to 80% was extracted by pepsin digestion, and 6 to 13% remained insoluble.
The nature of the pepsin-extracted collagen was further analyzed by gel electrophoresis (Fig.SB) could have been due to insufficient or ectopic expression of the transgene or to a subtle functional defect in the interspecies collagen molecule. Therefore, we analyzed the transcription pattern of the human COLlAl gene and the collagen produced in the transgenic mice.
The human transgene, under the control of its own promoter including 1.6 kb of 5'-flanking sequences and 20 kb of 3'-flanking sequences, was expressed in HucII and HucI mice at levels comparable to the endogenous COLlAl gene. An S1 nuclease protection assay also showed that the transgene was expressed in the appropriate tissue-specific manner. These results indicated that insufficient levels or inappropriate tissue distribution of the human proal(I) RNA could not explain the perinatal death of the Movl3 homozygous animals. The level of the COLlAl expression in previous experiments in which the same construct was transfected into SV40-transformed Movl3 tissue culture cells was much lower than in the transgenic animals (23) . This may be have been due to negative control elements in the collagen promoter which are sensitive to cellular transformation (22) .
Extensive biochemical characterization of the collagen produced in the transgenic animals revealed that the amounts of type I collagen present in the skin and bone of homozygous Movl3 newborns carrying the human transgene was comparable to those in normal wild-type mice. The stability of the triple helix and the cross-linking and morphology of the collagen fibrils were not distinguishable from those of normal mice. Therefore, by all criteria used, the interspecies heterotrimer was indistinguishable from the MOL. CELL. BIOL. normal mouse type I collagen, revealing no structural abnormalities which could have explained the failure to rescue homozygous Movl3 mice beyond birth.
In contrast to our previous finding, in which the collagen produced by Movl3 cells transfected with the human COLlAl gene (23) , no hypermodification of the collagen molecules was seen in the transgenic mice. We believe that the hypermodification seen in the previous experiments was peculiar to the particular cell clone analyzed, since electrophoretic studies suggested that other collagens were also affected. An unexpected finding was that the migration of the mouse and the human pNal(I) chain in SDS-gels differed, suggesting sequence difference in that region of the mouse and the human gene. This protein difference was seen in cells from transgenic fetuses and clearly demonstrated that the human proal(I) collagen chain was indeed incorporated into a mouse-human interspecies collagen I heterotrimer.
The interspecies collagen I was functioning normally in vivo throughout embryonic development but did not prevent postnatal death of homozygous Movl3 mice, which was characterized by profuse bleeding. We suggest two possible explanations for the failure of the interspecies collagen I heterotrimer to promote the survival of homozygous Movl3 mice beyond birth. It is possible, first, that the slight sequence differences between the human and the mouse proxl(I) chain results in a subtle functional defect of the hybrid protein, which becomes apparent only after birth when blood pressure rises, exerting particular demands on the stability of the circulatory system. For example, the different migration of the human and the mouse pNproal(I) may reveal a so far unrecognized function of the amino propeptide, which becomes manifest only when the human proal(I) chain associates with the mouse proa2(I) chain. The HucII/Movl3 mouse system may therefore be useful for studying subtle structural parameters which are important for the normal function of the type I collagen. Furthermore, we cannot exclude the possibility that a second gene distinct from the COLlAl gene is affected by the retrovirus insertion as well and that the lack of function of this second gene causes the perinatal death in homozygous Movl3 embryos carrying the human COLlAl transgene. To date, we have no evidence for another gene in the vicinity of the retrovirus insertion. We cannot exclude the possibility that a more distant gene is affected by the provirus. The available evidence, however, is consistent with the notion that a proviral genome may affect the function of only those gene-regulatory elements which are close to the insertion site rather than affecting the function of distant chromosomal regions. This is suggested by the observation that the Movl3 mutation affects the expression of the collagen d(1)I gene in a tissue-specific manner, repressing transcription in most mesenchymal cells but permitting expression in odontoblasts (14) .
At present we are introducing the mouse COLlAl gene into transgenic mice to distinguish between these models. Whatever the result of these studies might be, it is likely that the genetic manipulation of the Movl3 mutant strain will provide important insights into the function of type I collagen and/or other genes affected by the proviral insertion. 10, 1990 
